1. Home
  2. XOMAP vs LIDRW Comparison

XOMAP vs LIDRW Comparison

Compare XOMAP & LIDRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMAP
  • LIDRW
  • Stock Information
  • Founded
  • XOMAP N/A
  • LIDRW N/A
  • Country
  • XOMAP United States
  • LIDRW United States
  • Employees
  • XOMAP 13
  • LIDRW 60
  • Industry
  • XOMAP Biotechnology: Pharmaceutical Preparations
  • LIDRW Auto Parts:O.E.M.
  • Sector
  • XOMAP Health Care
  • LIDRW Consumer Discretionary
  • Exchange
  • XOMAP Nasdaq
  • LIDRW Nasdaq
  • Market Cap
  • XOMAP N/A
  • LIDRW N/A
  • IPO Year
  • XOMAP N/A
  • LIDRW 2021
  • Fundamental
  • Price
  • XOMAP $25.78
  • LIDRW $0.07
  • Analyst Decision
  • XOMAP
  • LIDRW
  • Analyst Count
  • XOMAP 0
  • LIDRW 0
  • Target Price
  • XOMAP N/A
  • LIDRW N/A
  • AVG Volume (30 Days)
  • XOMAP N/A
  • LIDRW N/A
  • Earning Date
  • XOMAP N/A
  • LIDRW N/A
  • Dividend Yield
  • XOMAP N/A
  • LIDRW N/A
  • EPS Growth
  • XOMAP N/A
  • LIDRW N/A
  • EPS
  • XOMAP N/A
  • LIDRW N/A
  • Revenue
  • XOMAP N/A
  • LIDRW N/A
  • Revenue This Year
  • XOMAP N/A
  • LIDRW N/A
  • Revenue Next Year
  • XOMAP N/A
  • LIDRW N/A
  • P/E Ratio
  • XOMAP N/A
  • LIDRW N/A
  • Revenue Growth
  • XOMAP N/A
  • LIDRW N/A
  • 52 Week Low
  • XOMAP N/A
  • LIDRW N/A
  • 52 Week High
  • XOMAP N/A
  • LIDRW N/A
  • Technical
  • Relative Strength Index (RSI)
  • XOMAP 56.05
  • LIDRW 48.98
  • Support Level
  • XOMAP $25.52
  • LIDRW $0.06
  • Resistance Level
  • XOMAP $25.70
  • LIDRW $0.09
  • Average True Range (ATR)
  • XOMAP 0.11
  • LIDRW 0.02
  • MACD
  • XOMAP 0.04
  • LIDRW -0.00
  • Stochastic Oscillator
  • XOMAP 91.37
  • LIDRW 24.33

About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About LIDRW AEye Inc. Warrant

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

Share on Social Networks: